{
    "nctId": "NCT02321527",
    "briefTitle": "Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients",
    "officialTitle": "Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Ultrasound Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Number of Breast Cancer Participants With Sentinel Lymph Nodes (SLN) Identification Using the CEUS Technique",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. 18 years or older.\n2. Ipsilateral biopsy-proven invasive breast cancer \\<5 cm in maximal dimension by Ultrasound or Mammography.\n3. No abnormal axillary nodes identified on grayscale AUS, or abnormal nodes with benign subsequent FNA biopsy.\n\nExclusion Criteria:\n\n1. Pregnant or nursing women\n2. Prior SLN dissection\n3. Neoadjuvant chemotherapy.\n4. Prior axillary lymph node surgery.\n5. Prior history of ipsilateral breast cancer.\n6. Known or suspected: Cardiac shunts\n7. Known or suspected: hypersensitivity to perflutren, blood, blood products or albumin\n8. Known or suspected: hypersensitivity to a prior OPTISON administration",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}